Fox Run Management, L.L.C. Dynavax Technologies Corp Transaction History

Fox Run Management, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 15, 2019	SELL	$8.14 - $13.28 $219,307 - $357,789	-26,942 Closed	0 $0
Q3 2018 Oct 05, 2018	BUY	$11.85 - $16.0 $319,262 - $431,072	26,942 New	26,942 $334,000
Q1 2018 Apr 17, 2018	SELL	$14.65 - $19.9 $201,437 - $273,625	-13,750 Closed	0 $0
Q4 2017 Jan 18, 2018	BUY	$17.3 - $24.08 $237,875 - $331,100	13,750	13,750 $257,000

276

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.62B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.